Publications of U. Reichl
All genres
Poster (295)
821.
Poster
Identification of parameters relevant for the quantification of intracellular metabolites in mammalian cell culture. ESBES 5, Stuttgart, Germany (2004)
822.
Poster
Quantitative Analysis of Energy Metabolism in Mammalian Cells. BioPerspectives 2004 (Dechema Jahrestagung), Wiesbaden, Germany (2004)
823.
Poster
Quantitative Mixed Culture Studies with Three Bacterial Species. ESBES 2004 - European Symbosium on Biochemical Engineering Science, Stuttgart, Germany (2004)
824.
Poster
Glycosylation of Influenza A Virus Hemagglutinin. CCE IX (Cell Culture Engineering IX) 2004, Riviera Maya , Cancun, QR, Mexico (2004)
825.
Poster
Glutamine-free media for vaccine production processes. 18th ESACT Meeting, Granada, Spain (2003)
826.
Poster
Optimization & Scale-up of Bioprocesses: Influenza Vaccine Production in Microcarrier Systems. Bioengineering Course (BEC), Supetar, Croatia (2003)
827.
Poster
Comparing wave and stirred-tank bioreactor performance for vaccine production with feline lung fibroblasts. 11th Congress on biotechnology, Basel, Switzerland (2003)
828.
Poster
Serum-free cultivation of CEF for vaccine production in microcarrier-systems. 18th ESACT Meeting, Granada, Spain (2003)
829.
Poster
Mathematical Modeling of MDCK Cell Growth by the Use of On-line Data. DECHEMA Jahrestagung der Biotechnologen, Munich, Germany (2003)
830.
Poster
Investigation of a new, sterile, deadvolume free sampling-system for universal applications, automated and suitable for online-analyzing. DECHEMA Jahrestagung der Biotechnologen, Munich, Germany (2003)
831.
Poster
Cooperation and competition: studies on heterogeneous microbial cultures. Jahrestagung der Vereinigung für allgemeine und angewandte Mikrobiologie (VAAM), Berlin, Germany (2003)
832.
Poster
Structured model of Influenza virus replication in MDCK cells. 11th Congress on biotechnology, Basel, Switzerland (2003)
833.
Poster
Analysis of cell growth, virus replication and medium composition in equine influenza vaccine production. IUMS 2002, Paris, France (2002)
834.
Poster
Analysis of cell growth, virus replication and medium composition in equine influenza vaccine production. GVC/Dechema Jahrestagungen 2002, Wiesbaden, Germany (2002)
835.
Poster
Development of bioprocess concepts on vaccine production: influenza virus as an example. 17th ESACT Meeting, Tyloesand, Sweden (2001)
Working Paper (3)
836.
Working Paper
Semi-continuous propagation of influenza A virus and its defective interfering particles: analyzing the dynamic competition to select candidates for antiviral therapy. bioRxiv (2021)
837.
Working Paper
Interferon induction and not replication interference mainly determines anti-influenza virus activity of defective interfering particles. bioRxiv (2021)
838.
Working Paper
Critical Assessment of Metaproteome Investigation (CAMPI): A Multi-Lab Comparison of Established Workflows. bioRxiv (2021)
Issue (1)
839.
Issue
10, (5) (2015)
Vaccine Biotechnology (Special issue). Biotechnology Journal Editorial (2)
840.
Editorial
Preface to Advances in Glycobiotechnology. Advances in Glycobiotechnology, pp. i - vi (2021)